- Home
- ZNTL vs MASS Comparison
ZNTL vs MASS Comparison
Compare ZNTL & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- MASS
- Stock Information
- Founded
- ZNTL 2014
- MASS 2012
- Country
- ZNTL United States
- MASS United States
- Employees
- ZNTL N/A
- MASS N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- MASS Medical/Dental Instruments
- Sector
- ZNTL Health Care
- MASS Health Care
- Exchange
- ZNTL Nasdaq
- MASS Nasdaq
- Market Cap
- ZNTL 102.2M
- MASS 84.3M
- IPO Year
- ZNTL 2020
- MASS 2020
- Fundamental
- Price
- ZNTL $1.28
- MASS $5.95
- Analyst Decision
- ZNTL Buy
- MASS Buy
- Analyst Count
- ZNTL 9
- MASS 3
- Target Price
- ZNTL $8.69
- MASS $5.33
- AVG Volume (30 Days)
- ZNTL 687.2K
- MASS 569.5K
- Earning Date
- ZNTL 05-14-2025
- MASS 05-13-2025
- Dividend Yield
- ZNTL N/A
- MASS N/A
- EPS Growth
- ZNTL N/A
- MASS N/A
- EPS
- ZNTL N/A
- MASS N/A
- Revenue
- ZNTL $26,865,000.00
- MASS $63,986,000.00
- Revenue This Year
- ZNTL N/A
- MASS N/A
- Revenue Next Year
- ZNTL N/A
- MASS $19.22
- P/E Ratio
- ZNTL N/A
- MASS N/A
- Revenue Growth
- ZNTL N/A
- MASS 32.85
- 52 Week Low
- ZNTL $1.01
- MASS $1.81
- 52 Week High
- ZNTL $12.68
- MASS $6.44
- Technical
- Relative Strength Index (RSI)
- ZNTL 41.45
- MASS 59.23
- Support Level
- ZNTL $1.18
- MASS $4.47
- Resistance Level
- ZNTL $1.27
- MASS $6.27
- Average True Range (ATR)
- ZNTL 0.07
- MASS 0.50
- MACD
- ZNTL 0.01
- MASS 0.07
- Stochastic Oscillator
- ZNTL 26.67
- MASS 71.50
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.